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diamine], is an anticonvulsant drug and has been used as antiepileptic 
to treat epilepsy and bipolar disorder as monotherapy and as an adjunct 
with other antiepileptics for treatment of partial and generalized toxic-
chronic seizures. It is also used to treat neurological lesions and as a 
tranquilizer [1,2]. Its chemical structure is given in figure 1.
LMT is not official in any pharmacopoeia. Chromatographic 
techniques have been widely employed for the determination of LMT 
in body fluids. Published methods for the determination of LMT in 
biological samples include high-performance liquid chromatography 
(HPLC) [3-10], high-performance thin layer chromatography 
(HPTLC) [11] and gas-chromatography (GC) [12] and for assay 
in pharmaceuticals include planar chromatography [13], TLC and 
HPLC [14], HPLC and GC [15] and capillary electrophoresis [16,17] 
have been reported. Two immunoassay techniques [18,19] have also 
been developed for determination of LMT in biological samples. Few 
methods have been reported for its determination in pharmaceuticals 
and include titrimetry [20] with acetous perchloric acid, in anhydrous 
acetic acid medium, UV- spectrophotometry [21] and visible 
spectrophotometry [22-25]. The uv-spectrophotometric method 
[21] was used for determination of LMT in tablets, where the tablet 
extract in 0.1 M NaOH was measured at 305 nm. Youssef and Taha 
[14] have reported the application of visible spectrophotometry for 
the determination of LMT using chloranilic acid as a chromogen. The 
reported method is less sensitive with a linear range 10-200 µgmL-1 and 
the molar absorptivity of 1.28×103 mol-1cm-1. Though the method is 
claimed to be selective, any N-containing basic moiety would definitely 
interfere with the assay. The extraction spectrophotometric methods 
[22-25] are at the other hand involves tedious extraction steps and 
consumes longer time for the analysis.
Many of the other reported methods [13-17] are sensitive and 
selective but they are time consuming, require expensive instrumental 
setup, and some require preliminary sample treatment. Adsorptive 
stripping voltammetric method [26] is highly complicated and is 
reported to be less precise (RSD, ~10%). Considering these drawbacks, 
there was a need to develop more advantageous spectrophotometric 
method for its determination in bulk powder and commercial dosage 
forms.
The objective of this investigation is to develop new simple, fast, 
sensitive, selective, reliable and inexpensive UV Spectrophotometric 
methods for the determination of LMT in bulk drug and commercial 
pharmaceutical formulations. The methods are based on the 
measurement of absorbance of LMT solution in either 0.1 M H2SO4 or 
methanol at 225 nm.
Experimental
Apparatus
The Spectrophotometric measurements were carried out using 
Shimadzu Pharmaspec 1700 UV/Visible spectrophotometer.
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Abstract
Two new simple, sensitive and cost-effective spectrophotometric methods for the determination of lamotrigine 
(LMT) in bulk drug and in tablets are described. The methods are based on the measurement of absorbance of LMT 
either in 0.1 M H2SO4 (method A) or in methanol (method B) at 225 nm. Linearity was found to be in the ranges, 0.5-
5.0 and 1.25-12.5 µgmL-1 LMT, for method A and method B, respectively with apparent molar absorptivity values of 
8.65×104 and 2.11×104 l mol-1cm-1. The Sandell sensitivity values, limits of detection (LOD) and quantification (LOQ) 
values have also been reported for both the methods. The accuracy and precision of the methods were evaluated on 
intra-day and inter-day basis; the relative error (%RE) and the relative standard deviation (RSD) were <2.0%. The 
proposed methods were applied to the determination of the examined drug in coated tablet and no interference from 
any common pharmaceutical additives and diluents was observed. Results of assay were validated statistically by 
parallel analysis and by recovery studies.
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Figure 1: Chemical structure of LMT.
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Chemicals and reagents
All chemicals used were of analytical reagent grade.
Pure LMT (pharmaceutical grade, 99.88%) sample was kindly 
provided by Cipla India Ltd, Mumbai, India, as a gift and used as 
received. Commercial dosage forms used: lamosyn 100 and lamosyn 25 
(both from Sun Pharmaceuticals Ltd, Mumbai, India) and Lametec 50-
DT (Cipla India Ltd, Mumbai, India)-all tablets were purchased from 
local commercial sources.
Standard solutions
Sulphuric acid (0.1 M) was prepared by successive dilutions of 
appropriate volume of concentrated acid (S.D. Fine Chem, Mumbai, 
India, sp. gr. 1.84) in water. Methanol AR (S.D. Fine Chem, Mumbai, 
India) was used as solvent in the present study.
Standard drug solution
Standard drug solutions of 10 µgmL-1 in 0.1 M H2SO4 and 25 µgmL-1 
LMT in methanol were prepared separately and used for assay in method 
A and method B, respectively.
Procedures
Recommended procedure and calibration curve
Method A: Varying amounts of aliquots (0.5, 1.0, 2,0, 3.0, 4.0 
and 5.0 mL) of working standard solution corresponding to 0.5-5.0 
µgmL-1 LMT were taken into a series of 10 mL volumetric flasks and 
volume was made upto mark with 0.1 M H2SO4. The absorbance of each 
solution was measured at 225 nm vs. 0.1 M H2SO4.
Method B: Into a series of 10 mL calibration flasks, aliquots of 
lamotrigine standard solution (25 µgmL-1) equivalent to 1.25-12.5 
µgmL-1 LMT were accurately transferred and volume was made upto 
mark with methanol. The absorbance of each solution was measured at 
225 nm vs. methanol.
In both the cases, calibration curves were plotted and the 
concentration of the unknown was read from the calibration graph or 
computed from the regression equation derived using Beer’s law data.
Procedure for tablets
Method A: Weighed amount of tablet powder equivalent to 10 mg 
of LMT was transferred into a 100 mL volumetric flask. The content 
was shaken well with about 50 mL of 0.1 M H2SO4 for 20 min. The 
mixture was diluted to the mark with the same acid. It was filtered 
using Whatman No 42 filter paper. First 10 mL portion of the filtrate 
was discarded and a subsequent portion was diluted to get a working 
concentration of 10 µgmL-1 and subjected to analysis following the 
procedure described earlier.
Method B: Tablet powder equivalent to 10 mg of LMT was 
transferred into a 100 mL volumetric flask. The content was shaken 
well with about 50 mL of methanol for 20 min and diluted to the mark 
with the same solvent. It was filtered using Whatman No 42 filter 
paper. First 10 mL portion of the filtrate was discarded and subsequent 
portion was analyzed after dilution to 25 µgmL-1 LMT with methanol.
Results and Discussion
Spectral characteristics
The LMT was dissolved either in 0.1 M H2SO4 (method A) or 
methanol (method B) and the absorbance measured at 225 nm, and at 
this wavelength blank solution had insignificant absorbance as shown 
by the absorption spectra in figure 2.
Method validation
Linearity, sensitivity, limits of detection and quantification: 
A linear correlation was found between absorbance at λmax and 
concentration of LMT in the ranges given in table 1. The graphs are 
described by the regression equation:
Y=a+bX (Where Y=absorbance of 1 cm layer of solution; 
a=intercept; b=slope and X=concentration in µgmL-1). Regression 
analysis of the Beer’s law data using the method of least squares was 
made to evaluate the slope (b), intercept (a) and correlation coefficient 
(r) for each system and the values are presented in Table 1. A plot of log 
absorbance vs. log concentration, yielded straight lines with slope equal 
to 0.991 and 1.02 for method A and method B, respectively, further 
establishing the linear relation between the two variables. The optical 
characteristics such as Beer’s law limits, molar absorptivity and Sandell 
sensitivity values [27] of all the three methods are also given in table 
1. The limits of detection (LOD) and quantitation (LOQ) calculated 
according to ICH guidelines [28] using the formulae: 
LOD=3.3 S/b and LOQ=10 S/b, (where S is the standard deviation 
of blank absorbance values, and b is the slope of the calibration plot) 














2 µg/mL LMT in 0.1 M H2SO4
(method A)
10 µg/mL LMT in methanol
(method B)
Figure 2: UV absorption spectra of LMT.
Parameter Method A Method B
λmax, nm 225 225
Linear range, µgmL-1 0.5-5.0 1.25-12.5
Molar absorptivity(ε), L mol-1cm-1 8.65×104 2.11×104
Sandell sensitivity*, µg cm-2 0.003 0.0121
Limit of detection (LOD), µgmL-1 0.01 0.03
Limit of quantification (LOQ), µgmL-1 0.02 0.09
Regression equation, Y**
Intercept (a) 0.0161 -0.0094
Slope (b) 0.3311 0.0849
Standard deviation of a (Sa) 0.0998 0.0998
Standard deviation of b (Sb) 0.032 0.0124
Variance (Sa2) 0.01 0.01
Regression coefficient (r) 0.9999 0.9999
*Limit of determination as the weight in µg per mL of solution, which corresponds to 
an absorbance of A=0.001 measured in a cuvette of cross-sectional area 1 cm2 
and l=1 cm. 
**Y=a+bX, Where Y is the absorbance, X is concentration in µgmL-1, a is intercept, 
b is slope.
Table 1: Sensitivity and regression parameters.
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Sandell sensitivity and LOD indicate the high sensitivity of the 
proposed methods.
Precision and accuracy: The assays described under “general 
procedures” were repeated seven times within the day to determine 
the repeatability (intra-day precision) and five times on different days 
to determine the intermediate precision (inter-day precision) of the 
methods. These assays were performed for three levels of analyte. The 
results of this study are summarized in table 2. The percentage relative 
standard deviation (%RSD) values were ≤ 1.96% (intra-day) and ≤ 
1.99% (inter-day) indicating high precision of the methods. Accuracy 
was evaluated as percentage relative error (RE) between the measured 
mean concentrations and taken concentrations for LMT. Bias {bias 
%=[(Concentration found-known concentration)×100/known 
concentration]} was calculated at each concentration and these results 
are also presented in table 2. Percent relative error (%RE) values of ≤ 
1.67% demonstrate the high accuracy of the proposed methods.
Selectivity: A systematic study was performed to determine the 
effect of matrix by analyzing the placebo blank and synthetic mixture 
containing LMT. A placebo blank of the composition: starch (10 mg), 
acacia (15 mg), hydroxyl cellulose (10 mg), sodium citrate (10 mg), talc 
(20 mg), magnesium stearate (15 mg) and sodium alginate (10 mg) 
was made and its solution was prepared as described under ‘tablets’, 
and then subjected to analysis. The absorbance of the placebo solution 
in each case was almost equal to the absorbance of the blank which 
revealed no interference. To assess the role of the inactive ingredients 
on the assay of LMT, a synthetic mixture was separately prepared 
by adding 10 mg of LMT to the placebo mentioned above. The drug 
was extracted and solution prepared as described under the general 
procedure for tablets.  The solutions after appropriate dilution were 
analyzed following the recommended procedures. The absorbance 
resulting from 3 and 8 µgmL-1 LMT solution in method A and method 
B, respectively, had nearly the same as those obtained for pure LMT 
solutions of identical concentrations. This unequivocally demonstrated 
the non-interference of the inactive ingredients in the assay of LMT. 
Further, the slopes of the calibration plots prepared from the synthetic 
mixture solutions were about the same as those prepared from pure 
drug solutions.
Robustness and ruggedness: The robustness of the methods was 
evaluated by making small incremental changes in the concentration 
of H2SO4 in method A. The results obtained from the altered acid 
conditions were not different compared to the optimum conditions. 
Method ruggedness was demonstrated having the analysis done by 
four analysts, and also by a single analyst performing analysis on four 
different instruments in the same laboratory. Intermediate precision 
values (%RSD) in both instances were in the range 0.88-1.65% 
indicating acceptable ruggedness. The results are presented in table 3.
Analysis of pharmaceutical formulations: The proposed methods 
were applied for the quantification of LMT in commercial tablets. The 
results were compared with these obtained using a published method 
[14]. The method consisted of the measurement of the absorbance of 
the charge-transfer complex of LMT with p-chloranilic acid in acetone 
at 519 nm. Statistical analysis of the results did not detect any significant 
difference between the performance of the proposed methods and 
reference method with respect to accuracy and precision as revealed 
by the Student’s t-value and variance ratio F-value [29]. The results of 
assay are given in table 4.
Recovery study: To further assess the accuracy of the methods, 
recovery experiments were performed by applying the standard-
addition technique. The recovery was assessed by determining the 
agreement between the measured standard concentration and added 
known concentration to the sample. The test was done by spiking the 
pre-analysed tablet powder with pure LMT at three different levels (50, 
100 and 150% of the content present in the tablet powder (taken) and 
the total was found by the proposed methods. Each test was repeated 
Method LMT taken, 
µg mL-1
Intra-day accuracy and precision 
(n=7)
Inter-day accuracy and precision
 (n=5)
LMT 
found ± CL,  
µg mL-1













































%RE. Percent relative error, %RSD. relative standard deviation and CL. Confidence limits were calculated from: CL= ± tS/√n. (The tabulated value of t is 2.45 and 2.77 
for six and four degrees of freedom respectively, at the 95% confidence level; S=standard deviation and n=number of measurements).
Table 2: Evaluation of intra-day and inter-day accuracy and precision.









A 6.0 1.56 0.88 1.65
B 8.0 - 0.99 1.58
*In method A, concentration of H2SO4 were 0.08, 0.1 and 0.12 M
Table 3: Method robustness and ruggedness expressed as intermediate precision (% RSD).
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three times. In all the cases, the recovery percentage values ranged 
between 100.8 and 105.1% with relative standard deviation in the range 
0.98-1.56%. Closeness of the results to 100% showed the fairly good 
accuracy of the methods. The results are shown in table 5.
Conclusions
Two UV-spectrophotometric methods for the determination of 





Found* (Percent of label claim  ±  SD)
Reference method Proposed methods
Method A Method B





















*Mean value of 5 determinations.
(Tabulated t-value at the 95% confidence level and for four degrees of freedom is 2.77).
(Tabulated F-value at the 95% confidence level and for four degrees of freedom is 6.39).
ψMarketed by : aSun pharmaceuticals.
 bCipla India Ltd, Mumbai.
Table 4: Results of analysis of tablets by the proposed methods and statistical comparison of the results with the reference method.
Tablet studied
Method A Method B
LMT in tablet, µg mL-1 Pure LMT added,  µgmL-1






































*Mean value of three determinations.
Table 5:  Results of recovery study via standard-addition method.
developed and validated for accuracy, precision, linearity, robustness 
and ruggedness. The proposed methods have better linear dynamic 
ranges and sensitivity compared to the reported uv [21] and visible 
[14] spectrophotometric methods (Table 6). The methods have the 
advantages of simplicity without involving heating or extraction step 
and high sensitivity. No interference due to co-formulated substances 
was observed when applied to the determination in tablets. Hence, 




(µg mL-1) Reaction time Remarks Ref.







2. 0.1 M NaOH LMT in NaOH was measured. 305 2-50 - - [21]
3
a) BCG/Dichloromethane Ion-pair extraction 410 1.5-15 1.3 5 min Tedious extraction procedure 
involved and Less sensitive [22]b) Alcoholic KOH Ion-pair breaking 620 0.5-5.0 0.59 Instantaneous
4
a) BPB/CHCl3 Ion-pair extraction 420 2.5-25 µg mL
-1 0.15 5 min




420 50-400 ng mL-1 0.003
Instantaneous [23]
c) Ethanolic KOH 600 10-80 ng mL-1 0.0005
5
a) BCP/dichloromethane Ion-pair extraction 410 2.0-20.0 µg mL-1 0.8 5 min
[24]b) Ethanol
Ion-pair breaking
410 150-1500 ng mL-1 0.06
Instantaneous




NA 0.15-19.8 µg mL-1 NA NA
[25]b) Bromocresol purple/CHCl3 NA 0.15-19.8 µg mL
-1 NA NA
c) Chlorophenol red/CHCl3 NA 0.05–34.1 µg mL
-1 NA NA
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a) 0.1 M H2SO4
















Table 6:  Performance characteristic of the existing spectrophotometric methods and the proposed methods.
the proposed methods could be adopted for quality control in 
pharmaceutical industries.
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